Proportion and trend of primary resistance among Multidrug resistant Tuberculosis patients in Ethiopia
- PMID: 35521633
- PMCID: PMC9062340
- DOI: 10.1016/j.jctube.2022.100315
Proportion and trend of primary resistance among Multidrug resistant Tuberculosis patients in Ethiopia
Abstract
Background: Evidence based information on the proportion & trend of primary resistance among multidrug resistance (MDR) TB patients is important for designing effective strategies in the control of the disease.
Methods: A retrospective record review of 348 MDR/RR-TB patients treated at All African Leprosy Rehabilitation & Training (ALERT) Center from January 2014- December 2018. Categorical variables were compared using Chi-square/Fisher exact test as appropriate. Trend analysis was done using chi-square & linear regression. Logistic regression analysis was done to determine the factors associated with primary MDR/RR TB. Adjusted Odds Ratio (AOR) with 95% CI and p value < 5% were used to report factors associated.
Result: Proportion of primary resistance among MDR/RR TB patients was 25.9% with 95% CI 21.3-30.3%. The proportion increased form 9.7% in 2014 to 43.4% in 2018 at a yearly increasing rate of 9.27%. Contact history to TB patient & year of diagnosis 2017 and 2018 were significantly associated with primary resistance AOR (95% CI) & p value 4.15(1.75-9.84) p = 0.001, 3.87(1.44-10.39) p = 0.007, 3.43(1.20-9.84) p = 0.022 respectively.
Conclusion: The study revealed a high proportion of primary resistance among MDR/RR TB during the study period with a linearly increasing fashion thus a need for due attention in the efforts to control MDR TB.
Keywords: Multidrug resistance TB; Primary drug resistance TB; Risk factors for drug resistance TB.
© 2022 The Author(s).
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- Khatua S., Geltemeyer A.M., Gourishankar A. Tuberculosis: Is the landscape changing? Pediatr Res. 2017;81(1–2):265–270. - PubMed
-
- Mathuria J.P., Samaria J.K., Srivastava G.N., Mathuria B.L., Ojha S.K., Anupurba S. Primary and acquired drug resistance patterns of Mycobacterium tuberculosis isolates in India: a multicenter study. J Infect Public Health. 2013;6(6):456–464. - PubMed
-
- GLOBAL TUBERCULOSIS REPORT 2017. GENEVA: WORLD HEALTH ORGANIGATION, 2017. Licence CC BY-NC-SA 3.0 1GO.
LinkOut - more resources
Full Text Sources